Dentsply Sirona Q1 2025 Earnings Report
Key Takeaways
Dentsply Sirona reported a decrease in net sales for Q1 2025, driven by a decline in the United States and Orthodontic and Implant Solutions segment. Despite the sales challenges, the company saw improvements in adjusted EBITDA margin and maintained its full-year adjusted EPS outlook.
Net sales for Q1 2025 were $879 million, a decrease of 7.7% compared to Q1 2024.
GAAP net income was $20 million, or $0.10 per share, a slight increase from $18 million or $0.09 per share in Q1 2024.
Adjusted EPS was $0.43, up from $0.42 in the prior year quarter.
The company maintained its full-year 2025 outlook for organic sales and adjusted EPS, while increasing reported sales outlook due to foreign exchange changes.
Dentsply Sirona
Dentsply Sirona
Dentsply Sirona Revenue by Segment
Dentsply Sirona Revenue by Geographic Location
Forward Guidance
Dentsply Sirona is maintaining its 2025 outlook for organic sales and adjusted EPS, while increasing its reported sales range due to foreign exchange rate changes.
Positive Outlook
- Maintaining 2025 organic sales outlook in the range of down (4.0%) to (2.0%).
- Maintaining 2025 adjusted EPS outlook in the range of $1.80 to $2.00.
- Increasing expected reported sales to a new range of $3.60 billion to $3.70 billion.
- Outlook reflects the current state of tariffs and trade policy.
- Focus on improving what is within their control to deliver sustainable long-term performance.
Challenges Ahead
- Organic sales outlook still indicates a potential decline.
- Operating in an increasingly uncertain macroeconomic environment.
- Does not provide forward-looking estimates on a GAAP basis.
- Certain information for GAAP estimates is not available without unreasonable effort.
- Exact amounts of potential future charges or credits are not currently determinable but may be significant.
Revenue & Expenses
Visualization of income flow from segment revenue to net income